The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
Clinical trial NCT06200844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06200844
- Sponsor
- Bharat Biotech International Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2025-01-04
- Enrollment
- 5800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.